You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Unresectable cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Unresectable or Metastatic Colorectal Cancer Trial in Shenyang (FOLFOX/FOLFIRI)

Recruiting
  • Unresectable or Metastatic Colorectal Cancer
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Mar 22, 2023

Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable

Recruiting
  • Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
  • +2 more
  • Best Practice
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Unresectable/Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib plus camrelizumab and capecitabine)

Recruiting
  • Unresectable/Metastatic Colorectal Cancer
  • Fruquintinib plus camrelizumab and capecitabine
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 19, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)

Not yet recruiting
  • Unresectable Pancreatic Cancer
  • creon 35.000 Ph.U (R)
  • Best Standarard of Care
  • (no location specified)
Oct 19, 2023

Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

Not yet recruiting
  • Unresectable Metastatic Colorectal Cancer
  • (no location specified)
Oct 25, 2023

Unresectable Gallbladder Cancer Trial in Guangzhou (Carrilizumab plus GEMOX)

Not yet recruiting
  • Unresectable Gallbladder Cancer
  • Carrilizumab plus GEMOX
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 16, 2023

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)

Not yet recruiting
  • Metastatic Breast Cancer
  • Unresectable Breast Cancer
  • DiviTum® TKa assay
  • CDK4/6 + Endocrine therapy
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 27, 2023

Unresectable Pancreatic Cancer Trial in Baltimore (NanoKnife IRE System)

Active, not recruiting
  • Unresectable Pancreatic Cancer
  • NanoKnife IRE System
  • Baltimore, Maryland
    University of Maryland Medical Center
Jan 30, 2023

Metastatic Pancreatic Cancer Trial (FOLFIRINOX treatment)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • FOLFIRINOX treatment
  • (no location specified)
Aug 9, 2023

Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Oct 5, 2023

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Deep Learning Radiogenomics For Individualized Therapy in

Recruiting
  • Gallbladder Cancer
  • CT scan
  • Chandigarh, Punjab, India
    Post Graduate Institute of Medical Education and Research
Feb 6, 2023

Gastric Cancer Trial in Tianjin (AK104, Apatinib, Paclitaxel)

Recruiting
  • Gastric Cancer
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 7, 2023

Unresectable Pancreatic Cancer Trial in Sendai-shi, Miyagi, Shinjuku-ku, Tokyo, Yokohama-shi, Kanagawa (Suizenji, Nal-IRI/FL,

Recruiting
  • Unresectable Pancreatic Cancer
  • Suizenji
  • +3 more
  • Sendai-shi, Miyagi, Japan
  • +2 more
Jan 31, 2023

Immunotherapy in Conversion Therapy of Unresectable Gastric

Recruiting
  • Unresectable Gastric Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Nov 8, 2022

    Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

    Not yet recruiting
    • Lung Cancer, Nonsmall Cell
    • Lung Cancer Stage III
    • Nivolumab and Chemotherapy
    • +3 more
    • (no location specified)
    Aug 15, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Colon Cancer Liver Metastases Trial (sequential adult left lateral lobe liver transplantation (SALT))

    Not yet recruiting
    • Colon Cancer Liver Metastases
    • sequential adult left lateral lobe liver transplantation (SALT)
    • (no location specified)
    Oct 3, 2023

    Breast Cancer Trial (SHR-A1811 for injection ; capecitabine)

    Not yet recruiting
    • Breast Cancer
    • SHR-A1811 for injection ; capecitabine
    • (no location specified)
    May 4, 2023

    Gallbladder Cancer, Initially Unresectable, the First Line Treatment Trial in Shanghai (Combination of Gemcitabine,

    Recruiting
    • Gallbladder Cancer
    • +2 more
    • Combination of Gemcitabine, Nab-paclitaxel, Sintilimab and Bevacizumab
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 24, 2023

    Unresectable Pancreatic Cancer, Unresectable Bile Duct Carcinoma, Unresectable Biliary Tract Carcinoma Trial (Tripegfilgrastim)

    Not yet recruiting
    • Unresectable Pancreatic Cancer
    • +2 more
    • (no location specified)
    Nov 13, 2023

    Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

    Recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Port Saint Lucie, Florida
    • +1 more
    Aug 11, 2023